Samsung Bioepis And C-Bridge Capital Deal Eyes Up ‘Next-Generation’ Biosimilars In China

 
• By Dean Rudge
ChinaWallFlag
Samsung Bioepis continues to make inroads in China. • Source: Shutterstock

More from Biosimilars

More from Products